Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
Open Access
- 1 January 2018
- journal article
- review article
- Published by Hindawi Limited in Clinical and Developmental Immunology
- Vol. 2018, 1-25
- https://doi.org/10.1155/2018/7394268
Abstract
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique features of this type of cancer frequently hamper the process of determining clinical presentation and predicting therapy effectiveness. The tumor can spontaneously regress without treatment or actively develop and give rise to metastases despite aggressive multimodal therapy. In recent years, immunotherapy has become one of the most promising approaches to the treatment of neuroblastoma. Still, only one drug for targeted immunotherapy of neuroblastoma, chimeric monoclonal GD2-specific antibodies, is used in the clinic today, and its application has significant limitations. In this regard, the development of effective and safe GD2-targeted immunotherapies and analysis of other potential molecular targets for the treatment of neuroblastoma represents an important and topical task. The review summarizes biological characteristics of the origin and development of neuroblastoma and outlines molecular markers of neuroblastoma and modern immunotherapy approaches directed towards these markers.Funding Information
- Russian Science Foundation (17-75-10211)
This publication has 259 references indexed in Scilit:
- Sox2-Mediated Regulation of Adult Neural Crest Precursors and Skin RepairStem Cell Reports, 2013
- Anaplastic Lymphoma Kinase Is Required for Neurogenesis in the Developing Central Nervous System of ZebrafishPLOS ONE, 2013
- Acquired resistance to drugs targeting receptor tyrosine kinasesBiochemical Pharmacology, 2012
- Activated ALK Collaborates with MYCN in Neuroblastoma PathogenesisCancer Cell, 2012
- CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?Current Colorectal Cancer Reports, 2011
- Emerging importance of ALK in neuroblastomaSeminars in Cancer Biology, 2011
- Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in DrosophilaCell, 2011
- Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside functionGlycoconjugate Journal, 2011
- Gangliosides in cell recognition and membrane protein regulationCurrent Opinion in Structural Biology, 2009
- Cryo-Electron Tomography of Homophilic Adhesion Mediated by the Neural Cell Adhesion Molecule L1Structure, 2009